Global Human Fibrinogen Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.
By product, the global Human Fibrinogen market is segmented into animal Fibrinogen and Human Fibrinogen Concentrate. Animal fibrinogen is still studying to confirm whether it produce toxic effect on human tissues or not after injection, it accounts for majority 0.47% market share of global revenue and Human Fibrinogen Concentrate accounts for majority 99.53% market share of global revenue in 2019.
By end user, the global Human Fibrinogen market is segmented into congenital fibrinogen deficiency and surgical procedures. In 2019, the Surgical Procedures application held the largest share in the global market and accounted for a market share of 91.74%. The Surgical Procedures is major segmented into trauma patients, cardiovascular surgery patients, PPH patients, and plastic surgery patients, accounting for 62.85%, 10.34%, 13.71%, and 1.31% respectively.
CSL is the leaders of the industry, with 52.52% market share of value in 2019, 32.44% market share of volume in 2019 and hold key technologies and patents. Other manufactures’ products are used to meet local demand. With further expanding market, there will be more players in the future.

Market Analysis and Insights: Global Human Fibrinogen Market
The global Human Fibrinogen market size is projected to reach US$ 1635.7 million by 2026, from US$ 689 million in 2020, at a CAGR of 15.5% during 2021-2026.
Global Human Fibrinogen Scope and Segment
The global Human Fibrinogen market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Fibrinogen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2015 to 2020. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.

Segment by Type, the Human Fibrinogen market is segmented into
Pure Human Fibrinogen
Fibrinogen Concentrate (Human)

Segment by Application, the Human Fibrinogen market is segmented into
Congenital Fibrinogen Deficiency
Surgical Procedures

Human Fibrinogen market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Fibrinogen business, the date to enter into the Human Fibrinogen market, Human Fibrinogen product introduction, recent developments, etc.
The major vendors covered:
CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Octapharma

Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Human Fibrinogen markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Human Fibrinogen market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.